Atlas Trials

An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007

Clinical trial NCT04168957 · TERMINATED

Trial details

NCT number
NCT04168957
Sponsor
Athenex, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Breastcancer
Start date
2017-10-25
Primary completion
2019-08-27
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.